One in Two: A Manchester Cancer Research Podcast
Season 2 - Lung Cancer: From basic biology to transformative therapies
Clinical trials with Professor Corinne Faivre-Finn: How RAPID RT could improve survival rates for lung cancer patients
With one in two of us receiving a cancer diagnosis at some point during our lives, it has never been more important to improve the outcomes for people affected by cancer.
In this episode, we speak to Corinne Faivre-Finn, a Professor of Thoracic Radiation Oncology at The University of Manchester and Honorary Clinician Oncologist at The Christie about lung cancer clinical trials, focussing on:
- Radiotherapy: what it is and how it’s used to treat lung cancers
- Clinical trials: what are they, who are they for and how are they set up
- The RAPID-RT clinical trial that launched at The Christie in early 2023, and how it could improve survival rates for lung cancer patients
- The involvement of AI and rapid learning in this trial, and the benefits this has for data collection
- Integrating patient voices into the trial
Radiotherapy is a very important treatment modality for patients who have cancer. It is used in approximately 40% of patients who have cancer, and it can be either a treatment that is given with intention to cure - which is called radical radiotherapy – or as a palliative treatment, where it is given with the intention of helping patients with whatever symptoms they might have.
Professor Corinne Faivre-Finn
Professor Corinne Faivre-Finn
Corinne Faivre-Finn, FRCR, MD, PhD, is a Professor of Thoracic Radiation Oncology at the Division of Molecular and Cancer Sciences (University of Manchester) and Honorary Consultant Clinical Oncologist (The Christie NHS Foundation Trust, Manchester) with a specialist interest in lung cancer.
Prof Faivre-Finn trained in Paris until 1998 and accepted a consultant post at The Christie in 2001. She has numerous professional roles including: Radiotherapy Research Lead and Radiotherapy Big Data Lead for Manchester Cancer Research Centre, Radiotherapy Research Lead for the CRUK Lung Cancer Centre of Excellence and Early NSCLC Chair of EORTC Lung Group. She is the Co-lead of the Christie/Manchester Cancer Research Centre Patient Reported Outcome Group.
The series has been produced in partnership with the Cancer Beacon at The University of Manchester.
Previous episodes from season one covering early detection research and other episodes from season two covering lung cancer research are available now on Spotify, Apple Podcasts, and The University of Manchester or MCRC YouTube Channel.
Cancer biomarkers with Professor Caroline Dive: How liquid biopsies could pave the way for lung cancer detection and treatment
The basic biology of lung cancer with Dr Colin Lindsay: Exploring oncogenic drivers such as the KRAS mutation
Season One now available – One in Two: A Manchester Cancer Research Podcast
One in Two: A Manchester Cancer Research Podcast